Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score

Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score

Background & aim: Patients with end-stage liver disease require valid estimations of mortality for organ allocation and risk stratification. The model of end-stage liver disease (MELD) score is used for this purpose in most countries and incorporates bilirubin, International Normalized ratio, an...

Full description

Bibliographic Details
Main Authors: Thorsten Kaiser, Benedict Kinny-Köster, Carsten Gnewuch, Diana Karailieva, Michael Kiehntopf, Anja Kessler, Christina Ritter-Sket, Michael Schmidt, Korbinian Brand, Joachim Thiery, Ralf Lichtinghagen
Format: Article
Language:English
Published: Elsevier 2017-08-01
Series:Practical Laboratory Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352551716300609

Internet

http://www.sciencedirect.com/science/article/pii/S2352551716300609

Similar Items